Pacific Equity, Carlyle to buy iNova Pharma for $930 mln

Pacific Equity Partners and Carlyle Group have agreed to buy iNova Pharmaceuticals for $930 million. Valeant Pharmaceuticals International is the seller. INova, of Australia, provides drugs for weight management, pain management, cardiology as well as cough and cold. Pacific Equity Partners and Carlyle were advised by Gilbert + Tobin, Allier Capital, Credit Suisse, Bank of America Merrill Lynch, UBS and Macquarie Bank.

DealsNorth AmericaUSBriefs